You just read:

Janssen Submits Application To U.S. FDA Seeking Approval Of STELARA® (ustekinumab) For Treatment Of Moderately To Severely Active Ulcerative Colitis

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Dec 20, 2018, 16:30 ET